$599
Autologous, Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other, Topics

Medtronic Launches Instinct CGM; SAB BIO Initiates Pivotal Ph2b T1DM Study; Lilly Terminates Ph2 Bimagrumab Study; Glooko Acquires Monarch Medical

A series of cardiometabolic-related news items has been observed from Medtronic, SAB BIO, Lilly, and Glooko. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here
OR
Return to Home